Alan Jardine

Has grant

Professor of Renal Medicine

University of Glasgow

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alan Jardine is a Professor of Renal Medicine at the University of Glasgow, UK. His research interests focus on cardiovascular safety and treatment efficacy in chronic kidney disease and hemodialysis patients, with recent publications investigating the effects of medications such as vadadustat and allopurinol. He also explores vascular access and the impact of vitamin K supplementation on kidney transplant recipients, contributing significantly to the field through randomized controlled trials and comparative studies.

Recent Grants

Grant: Close

Serum phosphate as a cardiovascular risk factor, effects on vascular and endothelial function

Open Date:

Close Date:

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Janet Peacock

Professor of Epidemiology and Biomedical Data Science

Dartmouth College

UNITED STATES

View details

Albert Power

University of Bristol

UNITED KINGDOM

View details

Ken Farrington

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alan Jardine

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial

A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

Safety and efficacy of vadadustat for anemia in patients undergoing dialysis

The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients

Vadadustat in patients with anemia and non-dialysis-dependent CKD

A comparative study of 5 different antibiotic prophylaxis regimes in 4500 total knee replacements

Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

Vitamin K for kidney transplant organ recipients: Investigating vessel stiffness (ViKTORIES): Study rationale and protocol of a randomised controlled trial

Collaborators (3)

Janet Peacock

Albert Power

Ken Farrington

Make your next move.